» Articles » PMID: 34337974

The Osteocyte As a Signaling Cell

Overview
Journal Physiol Rev
Specialty Physiology
Date 2021 Aug 2
PMID 34337974
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Osteocytes, former osteoblasts encapsulated by mineralized bone matrix, are far from being passive and metabolically inactive bone cells. Instead, osteocytes are multifunctional and dynamic cells capable of integrating hormonal and mechanical signals and transmitting them to effector cells in bone and in distant tissues. Osteocytes are a major source of molecules that regulate bone homeostasis by integrating both mechanical cues and hormonal signals that coordinate the differentiation and function of osteoclasts and osteoblasts. Osteocyte function is altered in both rare and common bone diseases, suggesting that osteocyte dysfunction is directly involved in the pathophysiology of several disorders affecting the skeleton. Advances in osteocyte biology initiated the development of novel therapeutics interfering with osteocyte-secreted molecules. Moreover, osteocytes are targets and key distributors of biological signals mediating the beneficial effects of several bone therapeutics used in the clinic. Here we review the most recent discoveries in osteocyte biology demonstrating that osteocytes regulate bone homeostasis and bone marrow fat via paracrine signaling, influence body composition and energy metabolism via endocrine signaling, and contribute to the damaging effects of diabetes mellitus and hematologic and metastatic cancers in the skeleton.

Citing Articles

A review of mathematical modeling of bone remodeling from a systems biology perspective.

Cook C, Lighty A, Smith B, Ford Versypt A Front Syst Biol. 2025; 4.

PMID: 40012834 PMC: 11864782. DOI: 10.3389/fsysb.2024.1368555.


Bone and muscle crosstalk in ageing and disease.

Kirk B, Lombardi G, Duque G Nat Rev Endocrinol. 2025; .

PMID: 40011751 DOI: 10.1038/s41574-025-01088-x.


Angiotensin II Promotes Osteocyte RANKL Expression via AT1R Activation.

Ren J, Marahleh A, Ma J, Ohori F, Noguchi T, Fan Z Biomedicines. 2025; 13(2).

PMID: 40002839 PMC: 11853621. DOI: 10.3390/biomedicines13020426.


Oversecretion of CCL3 by Irradiation-Induced Senescent Osteocytes Mediates Bone Homeostasis Imbalance.

Zhao F, Han H, Wang J, Wang J, Zhai J, Zhu G Cells. 2025; 14(4).

PMID: 39996722 PMC: 11853822. DOI: 10.3390/cells14040249.


Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases.

Li H, Zhang P, Lin M, Li K, Zhang C, He X Stem Cell Res Ther. 2025; 16(1):68.

PMID: 39940049 PMC: 11816542. DOI: 10.1186/s13287-025-04167-y.


References
1.
Loh N, Neville M, Marinou K, Hardcastle S, Fielding B, Duncan E . LRP5 regulates human body fat distribution by modulating adipose progenitor biology in a dose- and depot-specific fashion. Cell Metab. 2015; 21(2):262-273. PMC: 4321886. DOI: 10.1016/j.cmet.2015.01.009. View

2.
Lavi-Moshayoff V, Wasserman G, Meir T, Silver J, Naveh-Many T . PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol. 2010; 299(4):F882-9. DOI: 10.1152/ajprenal.00360.2010. View

3.
Papapoulos S, Lippuner K, Roux C, Lin C, Kendler D, Lewiecki E . The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study. Osteoporos Int. 2015; 26(12):2773-83. PMC: 4656716. DOI: 10.1007/s00198-015-3234-7. View

4.
Sasaki H, Nagura K, Ishino M, Tobioka H, Kotani K, Sasaki T . Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J Biol Chem. 1995; 270(36):21206-19. DOI: 10.1074/jbc.270.36.21206. View

5.
Plotkin L, Bellido T . Beyond gap junctions: Connexin43 and bone cell signaling. Bone. 2012; 52(1):157-66. PMC: 3513515. DOI: 10.1016/j.bone.2012.09.030. View